Argalas James S
Known title: DirectorCIK: 0001529312
Associated companies
Transaction History
| AX | ▼ Sell | Gift | 2,100 | $178K | 5/12/2026 | View on chart |
| AX | ▲ Buy | Option Exercise | 4,289 | $339K | 11/14/2025 | View on chart |
| AX | ▼ Sell | Other | 2,144 | $170K | 11/14/2025 | View on chart |
| AX | ▼ Sell | Gift | 1,100 | $97K | 8/12/2025 | View on chart |
| AX | ▼ Sell | Gift | 1,512 | $93K | 9/12/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,000 | $139K | 8/31/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 6,000 | $417K | 8/31/2024 | View on chart |
| AX | ▼ Sell | Other | 999 | $69K | 8/31/2024 | View on chart |
| AX | ▼ Sell | Other | 2,999 | $208K | 8/31/2024 | View on chart |
| AX | ▼ Sell | Gift | 3,000 | $152K | 3/12/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,667 | $115K | 8/31/2023 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,000 | $86K | 8/31/2023 | View on chart |
| AX | ▼ Sell | Other | 999 | $43K | 8/31/2023 | View on chart |
| AX | ▼ Sell | Other | 1,333 | $57K | 8/31/2023 | View on chart |
| AX | ▲ Buy | Option Exercise | 6,000 | $249K | 8/15/2023 | View on chart |
| AX | ▼ Sell | Other | 3,000 | $124K | 8/15/2023 | View on chart |
| AX | ▼ Sell | Gift | 3,056 | $145K | 2/22/2023 | View on chart |
| AX | ▲ Buy | Option Exercise | 4,667 | $195K | 8/31/2022 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,667 | $112K | 8/1/2022 | View on chart |
| AX | ▼ Sell | Gift | 2,750 | $131K | 3/15/2022 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,667 | $0 | 9/5/2021 | View on chart |
| AX | ▼ Sell | Other | 986 | $46K | 9/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Axos Financial Faces Valuation Debate Amid Analyst Support
Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.
Axos Financial Faces Valuation Debate Amid Analyst Support. Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.